Presentation ESC 2016 Edoxaban vs Enoxaparin-Warfarin in Subjects UndergoingCardioversion of Atrial Fibrillation Presenter: Andreas Goette August 30, 2016 REGISTER for free or LOG IN to view this content Coronary Presentation ESC 2016 Up Next Presentation Impact of Strut Width in Periprocedural MI Presenter: H. Kawamoto June 01, 2015 More slides + Presentation ESC 2016 CE-MARC 2 Trial: A Prospective, Multi-Centre, Randomized Trial Of 3 Diagnostic Strategies In Suspected Coronary Heart Disease (CMR vs UK NICE Guidelines vs MPS-SPECT) Presenter: John P. Greenwood August 29, 2016 Presentation Timing, Risk Factors, Outcomes of Stroke, TIA after TAVR: PARTNER Trial Presenter: Samir Kapadia September 12, 2016 We Recommend
Presentation ESC 2016 CE-MARC 2 Trial: A Prospective, Multi-Centre, Randomized Trial Of 3 Diagnostic Strategies In Suspected Coronary Heart Disease (CMR vs UK NICE Guidelines vs MPS-SPECT) Presenter: John P. Greenwood August 29, 2016
Presentation Timing, Risk Factors, Outcomes of Stroke, TIA after TAVR: PARTNER Trial Presenter: Samir Kapadia September 12, 2016